BEAT BIOTHERAPEUTICS

beat-biotherapeutics-logo

BEAT BioTherapeutics Corp. (BEATBio) is a Seattle, WA based biotechnology company founded to develop novel therapies for heart disease. BEAT Bioโ€™s first product is based on a fundamental discovery in cardiac muscle contraction and the development of a novel GeneTherapy to improve cardiac performance in the setting of heart failure.

#SimilarOrganizations #People #Financial #Website #More

BEAT BIOTHERAPEUTICS

Social Links:

Industry:
Biotechnology Medical Therapeutics

Founded:
2008-01-01

Address:
Bellevue, Washington, United States

Country:
United States

Website Url:
http://www.beatbiotherapeutics.com

Total Employee:
1+

Status:
Active

Contact:
2065430586

Email Addresses:
[email protected]

Total Funding:
2.5 M USD

Technology used in webpage:
Domain Not Resolving Google Font API Pound Sterling Japanese Yen


Similar Organizations

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

aperture-therapeutics-logo

Aperture Therapeutics

Aperture Therapeutics develops novel therapies for neurodegenerative diseases, leveraging genetic diversity.

c4-therapeutics-logo

C4 Therapeutics

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

not_available_image

D2M Biotherapeutics

D2M Biotherapeutics focuses on the development of novel immunotherapeutics.

lysosomal-therapeutics-logo

Lysosomal Therapeutics

Lysosomal Therapeutics deliver cures for neurodegenerative diseases.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

slingshot-biosciences-logo

Slingshot Biosciences

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.

tacere-therapeutics-logo

Tacere Therapeutics

Tacere Therapeutics develops therapies to identify and treat diseases.


Current Advisors List

not_available_image

Craig Tall Member of the Board @ BEAT BioTherapeutics
Board_member
2013-01-01

Current Employees Featured

not_available_image

Michael Laflamme
Michael Laflamme Scientific Co-Founder @ BEAT BioTherapeutics
Scientific Co-Founder

not_available_image

Michael Regnier
Michael Regnier Founder @ BEAT BioTherapeutics
Founder

not_available_image

Buddy Ratner
Buddy Ratner Scientific Co-Founder @ BEAT BioTherapeutics
Scientific Co-Founder

not_available_image

Charles Murry
Charles Murry Scientific Co-Founder and Chairman @ BEAT BioTherapeutics
Scientific Co-Founder and Chairman

Founder


not_available_image

Buddy Ratner

not_available_image

Charles Murry

not_available_image

Michael Laflamme

not_available_image

Michael Regnier

Investors List

w-fund_image

W Fund

W Fund investment in Seed Round - BEAT BioTherapeutics

cet-capital-partners_image

CET Capital Partners

CET Capital Partners investment in Seed Round - BEAT BioTherapeutics

Official Site Inspections

http://www.beatbiotherapeutics.com

Unable to get host informations!!!

Loading ...

More informations about "BEAT BioTherapeutics"

BEAT BioTherapeutics - Crunchbase Company Profile

BEAT BioTherapeutics Corp. (BEATBio) is a Seattle, WA based biotechnology company founded to develop novel therapies for heart disease. BEAT Bioโ€™s โ€ฆSee details»

BEAT Biotherapeutics Company Profile 2024: Valuation, Funding ...

BEAT Biotherapeutics General Information Description. Developer of novel therapies designed to treat heart failures. The company's therapies are used to treat heart failures by increasing โ€ฆSee details»

BEAT BioTherapeutics Corp - Company Profile and News

Company profile page for BEAT BioTherapeutics Corp including stock price, company news, executives, board members, and contact informationSee details»

BEAT BioTherapeutics - VentureRadar

BEAT BioTherapeutics is developing BB-R12, a novel biological therapy with the potential to revolutionize the treatment of heart failure. BEATBio holds worldwide rights to this technology โ€ฆSee details»

BEAT BioTherapeutics - Overview, News & Similar companies

BEAT BioTherapeutics Corp. (BEATBio) is a Seattle, WA based biotechnology company founded to develop novel therapies for heart disease. BEAT Bios f irst product is based on a โ€ฆSee details»

BEAT BioTherapeutics - Products, Competitors, Financials, โ€ฆ

BEAT BioTherapeutics Announces Scientific Presentation at American Society of Gene and Cell Therapy Annual Meeting. May 3, 2016. BEAT BioTherapeutics Announces Scientific โ€ฆSee details»

BEAT BioTherapeutics Corp.: Drug pipelines, Patents, Clinical trials ...

Explore BEAT BioTherapeutics Corp. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Technology Platform:AAV based gene ...See details»

BEAT BioTherapeutics - Funding, Financials, Valuation & Investors

BEAT BioTherapeutics develops novel therapies for heart diseases.See details»

BEAT BioTherapeutics Company Information - Funding, Investors, โ€ฆ

BEAT BioTherapeutics is a company founded to develop novel therapies for heart disease. Seedtable Score 76 Startups. 1. Funding Rounds. $2.5m. Money raised. About; Insights; โ€ฆSee details»

BEAT BioTherapeutics Corp Company Profile, Financial and

BEAT BioTherapeutics Corp., a biotechnology company, develops therapies for the treatment of heart diseases. The company focuses on developing a gene therapy to improve cardiac โ€ฆSee details»

Beat BioTherapeutics - Company Profile - Tracxn

Feb 26, 2025 Beat BioTherapeutics develops therapies for the treatment of heart diseases. The company focuses on developing a gene therapy to improve cardiac performance in the setting โ€ฆSee details»

BEAT BioTherapeutics - Ownership and Business Overview - Mergr

BEAT BioTherapeutics was founded in 2008. Life Science M&A Summary in . Join Mergr to view all 0 acquisitions of life science companies in , including . BEAT BioTherapeutics Corp. 1380 โ€ฆSee details»

BEAT BioTherapeutics - W Fund

BEAT BioTherapeutics Corp. (BEATBio) is a Seattle, WA based biotechnology company founded to develop novel therapies for heart disease. BEAT Bioโ€™s first product is based on a โ€ฆSee details»

BEAT BioTherapeutics Venture Capital and Private Equity Financings

BEATBio is a Seattle, Wash.-based biotechnology company focused on the development of a novel gene therapy for heart failure. BEATBio's technologies were developed by a founding โ€ฆSee details»

BEAT Bio Therapeutics - CoMotion

Jan 1, 2012 BEAT BioTherapeutics is developing BB-R12, a novel biological therapy with the potential to revolutionize the treatment of heart failure. BEATBio holds worldwide rights to this โ€ฆSee details»

BEAT BioTherapeutics - Company Information, Competitors, News โ€ฆ

Find useful insights on BEAT BioTherapeutics's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at BEAT โ€ฆSee details»

BEAT BioTherapeutics CEO, Founder, Key Executive Team, Board of ...

Explore {BEAT BioTherapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»

BEAT BioTherapeutics - Contacts, Employees, Board Members

BEAT BioTherapeutics has 4 current employee profiles, including Scientific Co-Founder Michael Laflamme. BEAT BioTherapeutics has 1 board member or advisor, Craig Tall . ContactsSee details»

BEAT BioTherapeutics Corporation Closes $2.5MM Seed Financing โ€ฆ

April 16, 2013 BEAT BioTherapeutics Corporation Closes $2.5MM Seed Financing to Develop Its Gene Therapy Treatment for Heart Failure University of Washington spin-out aims to refuel โ€ฆSee details»

BEAT Therapeutics - LinkedIn

BEAT Therapeutics Biotechnology Research Porto, Porto 1,922 followers First-in-class therapy against aggressive cancersSee details»

linkstock.net © 2022. All rights reserved